IP Verse

T Cell Activation Inhibitor, Pharmaceutical Composition Containing Same, And Screening Method For T Cell Activation Inhibiting Substance

Patent No. EP2510948 (titled "T Cell Activation Inhibitor, Pharmaceutical Composition Containing Same, And Screening Method For T Cell Activation Inhibiting Substance") was filed by Mitsubishi Tanabe Pharma on Dec 8, 2010. The application was issued on Sep 9, 2015.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ABBVIEJun 7, 2016MEWBURN ELLIS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2510948

MITSUBISHI TANABE PHARMA
Application Number
EP10835979A
Filing Date
Dec 8, 2010
Status
Revoked
Nov 9, 2022
Publication Date
Sep 9, 2015
External Links
Slate, Register , Google Patents